Rushford W A, Holman R M, Pulvertaft T B
J Int Med Res. 1978;6(2):141-3. doi: 10.1177/030006057800600213.
An open study is reported in which 35 general practitioners treated 128 patients suffering from 'Red Eye' with a new eye ointment containing 10% Tanderil(oxyphenbutazone) and 1% chloramphenicol. One hundred and seventeen patients completed the seven day treatment period, in which time 99 had completed resolution of the symptoms and were discharged, the remaining 18 patients needed a longer period of treatment. Eleven patients failed to complete the study period, of whom 5 patients were subsequently referred to a specialist and 6 had their treatment changed by the general practitioner. Six patients showed signs of allergy to the ointment, all of whom were being treated for allergic conjunctivitis. Seventeen per cent of patients had some difficulty in applying the eye ointment or complained of subsequent blurring of vision.
据报道,一项开放性研究中,35名全科医生用一种含有10%坦德瑞(羟基保泰松)和1%氯霉素的新型眼膏治疗了128例“红眼病”患者。117名患者完成了为期7天的治疗期,在此期间,99名患者症状完全缓解并出院,其余18名患者需要更长的治疗时间。11名患者未完成研究期,其中5名患者随后被转诊至专科医生处,6名患者的治疗由全科医生更改。6名患者表现出对眼膏过敏的迹象,所有这些患者均在接受过敏性结膜炎治疗。17%的患者在涂抹眼膏时遇到一些困难,或抱怨随后出现视力模糊。